Cabergoline Articles
Watson buy of Arrow requires product divestments, says USA’s FTC
4 December 2009
Japan's MTP to set up generics subsidiary
17 March 2008
Teva gets US OK for generic cabergoline
19 March 2007
Japan stock market week to Nov 20, 2006
27 November 2006
Japan stock market week to May 29, 2006
5 June 2006
Israel: complaints over funds' drug access
23 August 2004
Tokyo pharma stocks - week to August 16
23 August 2004
Tokyo pharma stocks - week to Nov 17
24 November 2003
Stock Commentary - Tokyo
24 November 2003
Pharmacia & Paladin sign Canadian distribution deal
28 January 2002
Pharmacia Canada has named Paladin Labs as the exclusive Canadian distributorhyperprolactinemia, Estring (estradiol vagi
28 January 2002
Pharmacia acquires remainder of Sensus
8 March 2001
Pharmacia's DAs as first-line therapy in PD
20 June 2000
P&U continues turnaround, looking for 1999 double-digit growth
29 October 1999
Euro neurodegenerative disease markets
24 February 1999
Neurodegenerative disease markets in Europe
19 February 1999
P&U Launches Cabaser In The UK
26 March 1997
Entacapone And Tolcapone Near Market Introduction
26 March 1997
P&U Launches Dostinex In The USA
20 March 1997
FDA Year-End Approval Spate As Expected
6 January 1997
P&U Moves To Revamp Inherited Pipeline
3 June 1996
Pharmacia & Upjohn First Combined Results
26 February 1996
P&U Files In USA For Parkinson's Drug
15 January 1996
Marriage Of Pharmacia And Upjohn Will Create New $13 Bill Drug Group
4 September 1995
Pharmacia Licenses Tolterodine To Kissei
31 July 1995
Pharmacia Pipeline Promises Future Growth
20 March 1995
ROUND-UP OF 1993'S NEW CHEMICAL ENTITIES
31 January 1994
ANALYSTS SAY PROCORDIA SPLIT IS SOUND LOGIC
19 July 1993
Showing 1-32 of 32 articles
- 1
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- New study shows UCB's Neupro reduces NSBP in RLS patient
